FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41071311000001103: Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2462271000001110 Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2462281000001112 Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Is a Tixagevimab 150mg/1.5ml solution for injection vials true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has specific active ingredient Tixagevimab true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) 1 vial Has AMP True Tixagevimab 150mg/1.5ml solution for injection vials (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start